Nurse Practitioner · Lexington, KY
NPI
1184739591
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1019 Majestic Dr, Suite 210
Lexington, KY, 40513
Phone (859) 277-3114
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
3,280 services
Medicare patients, 2024
287
Average age 70
Drug cost, 2024
$1.9M
4,506 prescriptions
Company payments, 2025
$3,653
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rose Pierson was code 95004 (test - miscellaneous), 2,242 times for 28 patients. In total Rose Pierson billed 3,280 services in 18 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 2,242 | 28 | $1.99 | $4,469 |
| 95115 Treatment - Miscellaneous | Office | 325 | 60 | $5.24 | $1,705 |
| 99213 Office E&M - Established | Office | 302 | 217 | $48.00 | $14K |
| 94010 Pulmonary Function Testing | Office | 161 | 120 | $14.26 | $2,297 |
| 99214 Office E&M - Established | Office | 88 | 75 | $63.91 | $5,624 |
| 95117 Treatment - Miscellaneous | Office | 80 | 17 | $6.21 | $497 |
By year: 2022 $42K for 4,350 services; 2023 $34K for 3,836 services; 2024 $30K for 3,280 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rose Pierson prescribed most often to Medicare patients was Ipratropium Bromide, with 662 prescriptions and refills. In total Rose Pierson wrote 4,506 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 662 | 901 | 264 | $19K |
| Montelukast Sodium Generic | 640 | 1,254 | 187 | $4,756 |
| Fluticasone Propionate Generic | 301 | 487 | 117 | $3,318 |
| Azelastine Hcl Generic | 286 | 400 | 102 | $5,588 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 277 | 330 | 133 | $8,261 |
| Levocetirizine Dihydrochloride Generic | 265 | 547 | 82 | $3,488 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 261 | 309 | 63 | $196K |
| Prednisone Generic | 219 | 220 | 154 | $373 |
| Xolair Omalizumab | 180 | 180 | 19 | $511K |
| Breo Ellipta Fluticasone/Vilanterol | 125 | 164 | 27 | $64K |
| Ventolin Hfa Albuterol Sulfate | 88 | 100 | 26 | $5,610 |
| Nucala Mepolizumab | 80 | 80 | Under 11 | $294K |
| Symbicort Budesonide/Formoterol Fumarate | 77 | 120 | 33 | $27K |
| Spiriva Respimat Tiotropium Bromide | 64 | 84 | 14 | $43K |
| Epinephrine Generic | 63 | 71 | 57 | $15K |
Brand drugs: 1,478 claims; generic drugs: 2,995 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rose Pierson $3,653 ($3,653 in general payments such as food, travel and fees) from 20 companies. The largest payer was GlaxoSmithKline, LLC. with $839.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 49 | $839 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $769 |
| CSL Behring CSL.AX | 22 | $427 |
| Genzyme Corporation SNY | 10 | $286 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $259 |
| LEO Pharma Inc. | 6 | $232 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $175 |
| Amgen Inc. AMGN | 9 | $169 |
| Verona Pharma, Inc. VRNA | 4 | $90.31 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $84.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.